StockData
Inventiva S.A. logo

Inventiva S.A. (IVA) stock

IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 1/30
$3.22−0.10 (-3.01%)

Close on Nov 17, 2026Market cap $622.22MP/E –Yield –

Inventiva cash

Cash and short-term investments held at the end of each period.

Inventiva's cash was €166.13M at Jun 30, 2026. For fiscal 2025 it was €99.31M, up 2.8% from the year before. The highest annual figure on record is €105.69M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025€99.31M+2.8%
FY2024Dec 31, 2024€96.56M+258.7%
FY2023Dec 31, 2023€26.92M-69.0%
FY2022Dec 31, 2022€86.74M+0.2%
FY2021Dec 31, 2021€86.55M-18.1%
FY2020Dec 31, 2020€105.69M+194.9%
FY2019Dec 31, 2019€35.84M-36.8%
FY2018Dec 31, 2018€56.69M-4.0%
FY2017Dec 31, 2017€59.05M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€166.13M+1537.2%
Q4 FY2025Dec 31, 2025€99.31M+268.9%
Q2 FY2025Jun 30, 2025€122.08M+290.8%
Q4 FY2024Dec 31, 2024€96.56M+11.3%
Q2 FY2024Jun 30, 2024€10.15M-86.7%
Q4 FY2023Dec 31, 2023€26.92M-68.9%
Q2 FY2023Jun 30, 2023€31.24M-70.4%
Q4 FY2022Dec 31, 2022€86.74M+142.0%
Q2 FY2022Jun 30, 2022€76.41M+34.8%
Q4 FY2021Dec 31, 2021€86.55M+46.6%
Q4 FY2020Dec 31, 2020€105.69M–
Q4 FY2019Dec 31, 2019€35.84M–
Q4 FY2018Dec 31, 2018€56.69M–
Q4 FY2017Dec 31, 2017€59.05M–

More Inventiva figures

See a number that looks wrong?